Simon Daenen
- Hematology top 1%
- Acute Myeloid Leukemia Research 17
- Hematopoietic Stem Cell Transplantation 10
- Chronic Myeloid Leukemia Treatments 7
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing 8
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 10
- Oncology top 5%
- Neutropenia and Cancer Infections 24
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility 7
-
- Acute Lymphoblastic Leukemia research 12
- Co-authors
- Edo VellengaBob LöwenbergM. R. HaliePeter C. HuijgensJan J. CornelissenLeo F. VerdonckHarry C. SchoutenAugustin Ferrant
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
Simon Daenen
78 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 103
- Hematology 1.0k
- Clinical Biochemistry 184
- Genetics 283
- Oncology 695
- Infectious Diseases 462
Countries citing papers authored by Simon Daenen
This map shows the geographic impact of Simon Daenen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Daenen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Daenen more than expected).
Fields of papers citing papers by Simon Daenen
This network shows the impact of papers produced by Simon Daenen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Daenen. The network helps show where Simon Daenen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Simon Daenen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 54 | |
| 2 | 2011 | 17 | |
| 3 | 2009 | 82 | |
| 4 | 2008 | 29 | |
| 5 | 2008 | 16 | |
| 6 | 2007 | 345 | |
| 7 | 2006 | 10 | |
| 8 | 2004 | 28 | |
| 9 | 2004 | 14 | |
| 10 | 2003 | 28 | |
| 11 | 2002 | 37 | |
| 12 | 2001 | 1 | |
| 13 | Antibiotics in granulocytopenic patients with fever. Drug selection by means of the SOJA method. | 2000 | 1 |
| 14 | 1995 | 3 | |
| 15 | Efficacy of etoposide and mitoxantrone in patients with acute myelogenous leukemia refractory to standard induction therapy and intermediate-dose cytarabine with amsidine. Dutch Hematology-Oncology Working Group for Adults (HOVON). | 1994 | 26 |
| 16 | 1992 | 3 | |
| 17 | 1992 | 39 | |
| 18 | 1987 | 2 | |
| 19 | 1986 | 11 | |
| 20 | 1986 | 14 |
About Simon Daenen
Simon Daenen is a scholar working on Hematology, Genetics and Clinical Biochemistry, having authored 78 papers that have together received 2.5k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (24 papers), Acute Myeloid Leukemia Research (17 papers), Acute Lymphoblastic Leukemia research (12 papers), Chronic Lymphocytic Leukemia Research (10 papers), Hematopoietic Stem Cell Transplantation (10 papers), Bacterial Identification and Susceptibility Testing (8 papers), Antifungal resistance and susceptibility (7 papers) and Chronic Myeloid Leukemia Treatments (7 papers). The work is most often cited by research in Hematology (1.0k citations), Clinical Biochemistry (184 citations) and Genetics (283 citations). Simon Daenen has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Edo Vellenga, Bob Löwenberg, M. R. Halie, Peter C. Huijgens, Jan J. Cornelissen, Leo F. Verdonck, Harry C. Schouten, Augustin Ferrant, Pierre W. Wijermans and Martin F. Fey. Their work appears in journals such as Blood, Leukemia Research, European Journal of Cancer, Annals of Hematology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.